vs
ATN International, Inc.（ATNI）とOrthofix Medical Inc.（OFIX）の財務データ比較。上の社名をクリックして会社を切り替えられます
Orthofix Medical Inc.の直近四半期売上が大きい（$219.9M vs $169.1M、ATN International, Inc.の約1.3倍）。Orthofix Medical Inc.の純利益率が高く（-1.0% vs -4.0%、差は3.0%）。Orthofix Medical Inc.の前年同期比売上増加率が高い（2.0% vs 1.2%）。Orthofix Medical Inc.の直近四半期フリーキャッシュフローが多い（$16.8M vs $7.1M）。過去8四半期でOrthofix Medical Inc.の売上複合成長率が高い（8.0% vs -1.1%）
ATN Internationalは米国マサチューセッツ州ビバリーに本社を置く上場通信企業で、旧社名はAtlantic Tele-Network, Inc.です。デジタル無線、固定回線、陸上・海底光ファイバー網の運営を手がけ、地理的に離れ地形的に難度の高い米国の平原、砂漠、山岳部などの市場にサービスを提供しています。
オーソフィックスメディカル社は世界的な整形外科医療機器メーカーで、脊椎インプラント、整形外科用外傷治療製品、骨成長刺激療法機器、再生医療製品の開発・製造・販売を事業としています。北米、欧州、アジア太平洋を中心に整形外科医や医療機関向けに製品を提供し、筋骨格系疾患患者の治療成績向上に取り組んでいます。
ATNI vs OFIX — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $169.1M | $219.9M |
| 純利益 | $-6.8M | $-2.2M |
| 粗利率 | — | 71.1% |
| 営業利益率 | 9.3% | 0.2% |
| 純利益率 | -4.0% | -1.0% |
| 売上前年比 | 1.2% | 2.0% |
| 純利益前年比 | -261.7% | 92.4% |
| EPS（希薄化後） | $-0.31 | $-0.05 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $169.1M | $219.9M | ||
| Q3 25 | $166.9M | $205.6M | ||
| Q2 25 | $166.5M | $203.1M | ||
| Q1 25 | $164.6M | $193.6M | ||
| Q4 24 | $167.1M | $215.7M | ||
| Q3 24 | $164.6M | $196.6M | ||
| Q2 24 | $169.4M | $198.6M | ||
| Q1 24 | $172.9M | $188.6M |
| Q4 25 | $-6.8M | $-2.2M | ||
| Q3 25 | $3.9M | $-22.8M | ||
| Q2 25 | $-9.3M | $-14.1M | ||
| Q1 25 | $-11.4M | $-53.1M | ||
| Q4 24 | $4.2M | $-29.1M | ||
| Q3 24 | $-39.5M | $-27.4M | ||
| Q2 24 | $11.3M | $-33.4M | ||
| Q1 24 | $-7.9M | $-36.0M |
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
| Q4 25 | 9.3% | 0.2% | ||
| Q3 25 | 5.9% | -8.3% | ||
| Q2 25 | 0.1% | -7.9% | ||
| Q1 25 | 1.6% | -25.2% | ||
| Q4 24 | 5.2% | -5.3% | ||
| Q3 24 | -23.3% | -9.6% | ||
| Q2 24 | 14.4% | -12.5% | ||
| Q1 24 | 2.6% | -15.6% |
| Q4 25 | -4.0% | -1.0% | ||
| Q3 25 | 2.4% | -11.1% | ||
| Q2 25 | -5.6% | -6.9% | ||
| Q1 25 | -6.9% | -27.4% | ||
| Q4 24 | 2.5% | -13.5% | ||
| Q3 24 | -24.0% | -13.9% | ||
| Q2 24 | 6.7% | -16.8% | ||
| Q1 24 | -4.6% | -19.1% |
| Q4 25 | $-0.31 | $-0.05 | ||
| Q3 25 | $0.18 | $-0.57 | ||
| Q2 25 | $-0.56 | $-0.36 | ||
| Q1 25 | $-0.69 | $-1.35 | ||
| Q4 24 | $0.16 | $-0.76 | ||
| Q3 24 | $-2.26 | $-0.71 | ||
| Q2 24 | $0.50 | $-0.88 | ||
| Q1 24 | $-0.50 | $-0.95 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $102.9M | $82.0M |
| 総負債低いほど良い | $565.2M | — |
| 株主資本純資産 | $444.3M | $450.0M |
| 総資産 | $1.7B | $850.6M |
| 負債/資本比率低いほどレバレッジが低い | 1.27× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $102.9M | $82.0M | ||
| Q3 25 | $106.6M | $62.9M | ||
| Q2 25 | $99.4M | $65.6M | ||
| Q1 25 | $83.8M | $58.0M | ||
| Q4 24 | $73.7M | $83.2M | ||
| Q3 24 | $101.0M | $30.1M | ||
| Q2 24 | $59.2M | $26.4M | ||
| Q1 24 | $56.8M | $27.0M |
| Q4 25 | $565.2M | — | ||
| Q3 25 | $579.6M | $157.2M | ||
| Q2 25 | $583.4M | $157.0M | ||
| Q1 25 | $562.4M | $156.9M | ||
| Q4 24 | $557.4M | $157.0M | ||
| Q3 24 | $568.9M | $118.5M | ||
| Q2 24 | $540.8M | $118.0M | ||
| Q1 24 | $541.3M | $118.2M |
| Q4 25 | $444.3M | $450.0M | ||
| Q3 25 | $452.3M | $442.5M | ||
| Q2 25 | $458.7M | $458.3M | ||
| Q1 25 | $473.3M | $458.3M | ||
| Q4 24 | $489.5M | $503.1M | ||
| Q3 24 | $490.8M | $525.9M | ||
| Q2 24 | $526.8M | $546.0M | ||
| Q1 24 | $530.0M | $570.3M |
| Q4 25 | $1.7B | $850.6M | ||
| Q3 25 | $1.7B | $832.6M | ||
| Q2 25 | $1.7B | $837.2M | ||
| Q1 25 | $1.7B | $823.1M | ||
| Q4 24 | $1.7B | $893.3M | ||
| Q3 24 | $1.8B | $867.9M | ||
| Q2 24 | $1.8B | $882.0M | ||
| Q1 24 | $1.8B | $906.0M |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 1.28× | 0.36× | ||
| Q2 25 | 1.27× | 0.34× | ||
| Q1 25 | 1.19× | 0.34× | ||
| Q4 24 | 1.14× | 0.31× | ||
| Q3 24 | 1.16× | 0.23× | ||
| Q2 24 | 1.03× | 0.22× | ||
| Q1 24 | 1.02× | 0.21× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $36.2M | $27.7M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.1M | $16.8M |
| FCFマージンFCF / 売上 | 4.2% | 7.6% |
| 設備投資強度設備投資 / 売上 | 17.2% | 4.9% |
| キャッシュ転換率営業CF / 純利益 | — | — |
| 直近12ヶ月FCF直近4四半期 | $43.9M | $-1.3M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $36.2M | $27.7M | ||
| Q3 25 | $37.8M | $12.4M | ||
| Q2 25 | $23.9M | $11.6M | ||
| Q1 25 | $35.9M | $-18.4M | ||
| Q4 24 | $30.5M | $23.7M | ||
| Q3 24 | $39.0M | $11.7M | ||
| Q2 24 | $35.2M | $9.0M | ||
| Q1 24 | $23.2M | $-18.6M |
| Q4 25 | $7.1M | $16.8M | ||
| Q3 25 | $18.9M | $2.5M | ||
| Q2 25 | $2.8M | $4.5M | ||
| Q1 25 | $15.1M | $-25.1M | ||
| Q4 24 | $5.8M | $15.2M | ||
| Q3 24 | $15.2M | $6.3M | ||
| Q2 24 | $9.4M | $-360.0K | ||
| Q1 24 | $-12.8M | $-29.1M |
| Q4 25 | 4.2% | 7.6% | ||
| Q3 25 | 11.3% | 1.2% | ||
| Q2 25 | 1.7% | 2.2% | ||
| Q1 25 | 9.2% | -13.0% | ||
| Q4 24 | 3.5% | 7.0% | ||
| Q3 24 | 9.2% | 3.2% | ||
| Q2 24 | 5.6% | -0.2% | ||
| Q1 24 | -7.4% | -15.4% |
| Q4 25 | 17.2% | 4.9% | ||
| Q3 25 | 11.3% | 4.8% | ||
| Q2 25 | 12.7% | 3.5% | ||
| Q1 25 | 12.7% | 3.5% | ||
| Q4 24 | 14.8% | 4.0% | ||
| Q3 24 | 14.5% | 2.7% | ||
| Q2 24 | 15.2% | 4.7% | ||
| Q1 24 | 20.8% | 5.6% |
| Q4 25 | — | — | ||
| Q3 25 | 9.62× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 7.24× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.11× | — | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ATNI
| Us Telecommunications | $86.9M | 51% |
| Fixed Consumer | $42.8M | 25% |
| Fixed Business | $18.5M | 11% |
| Transferred At Point In Time | $7.2M | 4% |
| Mobility Business | $5.3M | 3% |
| Other Revenue | $4.2M | 2% |
| Other Communication Services | $3.2M | 2% |
| Managed Services | $1.2M | 1% |
| Construction Services | $448.0K | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
